Startup profile for Abridge: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Abridge funding, valuation and investors

AI medical scribe capturing clinician-patient conversations into structured EHR notes.

Keep track of Abridge

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series E

$300M · June 2025

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$450M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · San Francisco, California

Investors in latest funding

Lead: Andreessen Horowitz

Other: Khosla Ventures

Sources: latest funding Last verified: 2026-07-25

Overview

Abridge records clinician-patient conversations and uses AI to generate structured clinical notes integrated into EHR workflows. The Pittsburgh-founded company sells to health systems competing in the AI medical scribe category alongside Ambience and others. Abridge raised $150M Series C in February 2024 co-led by Lightspeed and Redpoint, and a reported $300M Series E in June 2025 led by Andreessen Horowitz with Khosla Ventures participating.

Why Abridge is interesting

Abridge lands enterprise hospital contracts in the crowded AI scribe war — clinical documentation drives physician burnout, and distribution to health systems separates leaders from demo vendors.

Product & use cases

AI ambient documentation — records medical encounters and produces structured clinical notes pushed into Epic and other EHR systems.

  • Hospital and clinic ambient clinical documentation
  • Physician burnout reduction via automated charting
  • Enterprise health system AI scribe deployment

Key facts

  • Series E (Jun 2025): $300M led by a16z; Khosla participated (STAT News)
  • Series C (Feb 2024): $150M co-led by Lightspeed and Redpoint
  • Enterprise hospital AI scribe with EHR integrations
  • Competes with Ambience, Nuance DAX in clinical documentation

Funding history (newest first)

Series E

2025-06 $300M

Source: https://www.abridge.com/

Series C

2024-02 $150M

Source: https://www.abridge.com/press

Investors in our directory

Funds linked from Abridge's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz Bessemer Venture Partners Khosla Ventures Lightspeed Venture Partners Redpoint Ventures Spark Capital Union Square Ventures

Competitive landscape

Edge: Enterprise hospital distribution and EHR integrations in competitive AI scribe market.

AI scribe market is crowded post-GPT boom. Abridge wins on health system contracts and workflow integration; Nuance/Microsoft bundling is major incumbent threat.

  • Ambience Healthcare direct

    Enterprise AI scribe competitor; similar hospital GTM.

  • Nuance DAX incumbent

    Microsoft-owned ambient clinical documentation.

  • DeepScribe direct

    AI medical scribe; overlapping specialty focus.

Notable stories

  • $300M Series E reflects AI scribe category landing multi-hospital enterprise deals.
  • Clinical documentation as top physician burnout driver keeps scribe budgets funded.

Industries

Healthtech AI & Machine Learning

FAQs about Abridge

Practical answers founders, operators, and investors typically search for.

Captures medical conversations and auto-generates clinical documentation integrated into EHR workflows.
a16z (/fund/andreessen-horowitz), Lightspeed (/fund/lightspeed-venture-partners-nyc), Redpoint (/fund/redpoint-ventures), Spark (/fund/spark-capital), USV (/fund/union-square-ventures), Bessemer (/fund/bessemer-venture-partners), Khosla (/fund/khosla-ventures).
Both enterprise AI scribes; compete on hospital contracts, specialty coverage, and EHR integration depth.
Series C $150M (Feb 2024); Series E $300M (Jun 2025).
No — private as of July 2026.
Documentation is a leading physician burnout driver; health systems pay for ambient charting that integrates with Epic.
Epic integration prominently marketed; verify full EHR list on abridge.com.
Not publicly disclosed.
Late-stage private growth after $300M Series E.
Hospital systems and clinic groups adopting ambient clinical documentation.
See fundraisingRounds — amounts only when verified in press or company announcements.
See competitors section for named alternatives.
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.